Free Trial

Apollomics (APLM) Competitors

Apollomics logo
$26.93 -3.17 (-10.53%)
Closing price 04:00 PM Eastern
Extended Trading
$25.84 -1.09 (-4.03%)
As of 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

APLM vs. IZTC, UNCY, RPTX, VXRT, LITS, XBIT, HOWL, CRVO, PMVP, and COEP

Should you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include Invizyne Technologies (IZTC), Unicycive Therapeutics (UNCY), Repare Therapeutics (RPTX), Vaxart (VXRT), Lite Strategy (LITS), XBiotech (XBIT), Werewolf Therapeutics (HOWL), CervoMed (CRVO), PMV Pharmaceuticals (PMVP), and Coeptis Therapeutics (COEP). These companies are all part of the "pharmaceutical products" industry.

Apollomics vs. Its Competitors

Apollomics (NASDAQ:APLM) and Invizyne Technologies (NASDAQ:IZTC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends, media sentiment and valuation.

19.1% of Apollomics shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Apollomics had 20 more articles in the media than Invizyne Technologies. MarketBeat recorded 20 mentions for Apollomics and 0 mentions for Invizyne Technologies. Apollomics' average media sentiment score of 0.18 beat Invizyne Technologies' score of 0.00 indicating that Apollomics is being referred to more favorably in the media.

Company Overall Sentiment
Apollomics Neutral
Invizyne Technologies Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Apollomics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Invizyne Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
Invizyne Technologies N/A N/A N/A

Invizyne Technologies has lower revenue, but higher earnings than Apollomics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$1.49M19.88-$53.86MN/AN/A
Invizyne TechnologiesN/AN/AN/AN/AN/A

Summary

Apollomics beats Invizyne Technologies on 5 of the 5 factors compared between the two stocks.

Get Apollomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APLM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APLM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APLM vs. The Competition

MetricApollomicsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$33.21M$3.48B$6.17B$10.69B
Dividend YieldN/A2.26%5.72%4.83%
P/E RatioN/A23.0629.1427.22
Price / Sales19.88482.28580.06129.95
Price / CashN/A47.5937.5161.65
Price / Book6.0110.6612.476.59
Net Income-$53.86M-$52.56M$3.32B$276.14M
7 Day Performance46.12%4.97%1.87%0.01%
1 Month PerformanceN/A16.48%8.40%3.60%
1 Year Performance96.86%14.95%63.49%32.76%

Apollomics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APLM
Apollomics
0.2457 of 5 stars
$26.93
-10.5%
N/A+135.0%$33.21M$1.49M0.0045Gap Up
IZTC
Invizyne Technologies
N/A$12.95
-4.1%
N/AN/A$80.96MN/A0.0029Gap Up
UNCY
Unicycive Therapeutics
2.6668 of 5 stars
$4.56
+1.6%
$57.00
+1,150.0%
+16.6%$80.53M$680K-1.119
RPTX
Repare Therapeutics
2.7759 of 5 stars
$1.87
+2.7%
$4.50
+140.6%
-45.2%$80.34M$53.48M-0.72180Gap Up
VXRT
Vaxart
1.7712 of 5 stars
$0.34
+1.3%
$2.00
+482.2%
-56.7%$78.64M$47.40M-1.27120News Coverage
LITS
Lite Strategy
N/A$2.19
+1.9%
N/AN/A$78.07M$65.30M-0.46100Positive News
XBIT
XBiotech
2.117 of 5 stars
$2.51
-2.0%
N/A-67.2%$76.53M$4.01M-2.73100News Coverage
Short Interest ↓
HOWL
Werewolf Therapeutics
3.8757 of 5 stars
$1.67
+2.5%
$8.00
+379.0%
-21.0%$76.37MN/A-1.0240
CRVO
CervoMed
3.4277 of 5 stars
$8.22
+2.6%
$19.29
+134.6%
-47.5%$76.04M$9.74M-3.154News Coverage
PMVP
PMV Pharmaceuticals
2.6021 of 5 stars
$1.42
+7.6%
$5.50
+287.3%
-7.0%$75.25MN/A-0.9050High Trading Volume
COEP
Coeptis Therapeutics
0.7413 of 5 stars
$15.53
-0.1%
N/A+261.3%$74.86MN/A-2.682News Coverage
Short Interest ↑

Related Companies and Tools


This page (NASDAQ:APLM) was last updated on 10/21/2025 by MarketBeat.com Staff
From Our Partners